Skip to main content
. 2017 Mar 14;17:75. doi: 10.1186/s12872-017-0508-3

Table 2.

Treatment

STEMI N = 4899 NSTEMI N = 5159
Women n = 1214 Men n = 3685 p-value Women n = 1776 Men n = 3383 p-value
Pre-hospital thrombolysis, n (%)a 105 (8.6) 429 (11.7) 0.004 - - -
Coronary angiography, n (%) 1115 (91.9) 3591 (97.5) <0.0001 1200 (67.6) 2925 (86.5) <0.0001
Normal vessels, n (%)b 21 (1.9) 52 (1.5) 0.307 157 (13.2) 114 (3.9) <0.0001
Atheromatosis, n (%)b 23 (1.9) 48 (1.3) 0.083 126 (10.6) 136 (4.7) <0.0001
One-vessel disease, n (%)b 539 (48.4) 1630 (45.5) 0.086 396 (33.2) 1145 (39.4) 0.0002
Multiple-vessel or LMS disease, n (%)b 530 (47.6) 1853 (51.9) 0.017 512 (43.0) 1513 (52.0) <0.0001
Missing angiogram, n (%)b 2 (0.2) 8 (0.2) NS 8 (0.7) 17 (0.6) NS
Primary PCI, n (%)c 808 (66.5) 2653 (72.0) 0.0003 - - -
All PCI, n (%) 936 (77.0) 3160 (85.7) <0.0001 524 (29.5) 1598 (47.2) <0.0001
CABG, n (%) 37 (3.0) 187 (5.1) 0.003 109 (6.1) 423 (12.5) <0.0001
Door to balloon-time, minutesd 38 (29–55) 36 (29–52) 0.043 - - -
Symptom to balloon-time, minutesd 270 (170–495) 245 (155–456) 0.001 - - -
Symptom to angiography, daysd - - - 2 (1–4) 2 (1–4) <0.0001

LMS Left main stem, PCI percutaneous coronary intervention, CABG Coronary artery bypass grafting

(%) = percent of patients with available information, denominator may vary

Pre-hospital or in local hospital

among patients who underwent coronary angiography

PCI ≤ 12 h from onset of symptoms, without prior thrombolysis

median (25th–75th percentile)